$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe and Res ... | Payment of Exercise | F | 181.48 | 2,729 | 495,259 | 21,967 | 24.7 K to 22 K (-11.05 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Payment of Exercise | F | 181.48 | 4,565 | 828,456 | 41,855 | 46.4 K to 41.9 K (-9.83 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Payment of Exercise | F | 181.48 | 4,565 | 828,456 | 59,102 | 63.7 K to 59.1 K (-7.17 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Payment of Exercise | F | 181.79 | 978 | 177,791 | 63,667 | 64.6 K to 63.7 K (-1.51 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 183.36 | 4 | 733 | 14,659 | 14.7 K to 14.7 K (-0.03 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 179.98 | 797 | 143,444 | 14,663 | 15.5 K to 14.7 K (-5.16 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,310 | 0 | 15,460 | 14.2 K to 15.5 K (+9.26 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 177.71 | 10 | 1,777 | 5,384 | 5.4 K to 5.4 K (-0.19 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 177.82 | 644 | 114,516 | 5,394 | 6 K to 5.4 K (-10.67 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 184.06 | 4 | 736 | 6,038 | 6 K to 6 K (-0.07 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 179.98 | 797 | 143,444 | 6,042 | 6.8 K to 6 K (-11.65 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,310 | 0 | 6,839 | 5.5 K to 6.8 K (+23.69 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Grant | A | 0.00 | 1,310 | 0 | 3,810 | 2.5 K to 3.8 K (+52.40 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 183.36 | 4 | 733 | 4,865 | 4.9 K to 4.9 K (-0.08 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 179.98 | 797 | 143,444 | 4,869 | 5.7 K to 4.9 K (-14.07 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,310 | 0 | 5,666 | 4.4 K to 5.7 K (+30.07 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 1,310 | 0 | 10,742 | 9.4 K to 10.7 K (+13.89 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Grant | A | 0.00 | 1,310 | 0 | 1,158,515 | 1.2 M to 1.2 M (+0.11 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Sell | S | 182.31 | 4 | 729 | 6,093 | 6.1 K to 6.1 K (-0.07 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Sell | S | 179.98 | 863 | 155,323 | 6,097 | 7 K to 6.1 K (-12.40 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Grant | A | 0.00 | 1,310 | 0 | 6,960 | 5.7 K to 7 K (+23.19 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 184.06 | 4 | 736 | 5,389 | 5.4 K to 5.4 K (-0.07 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 179.98 | 863 | 155,323 | 5,393 | 6.3 K to 5.4 K (-13.79 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Grant | A | 0.00 | 1,310 | 0 | 6,256 | 4.9 K to 6.3 K (+26.49 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 183.75 | 21 | 3,859 | 5,500 | 5.5 K to 5.5 K (-0.38 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 182.69 | 23 | 4,202 | 5,521 | 5.5 K to 5.5 K (-0.41 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 181.71 | 148 | 26,893 | 5,544 | 5.7 K to 5.5 K (-2.60 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 180.05 | 4 | 720 | 5,692 | 5.7 K to 5.7 K (-0.07 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 183.77 | 1,069 | 196,450 | 274,500 | 275.6 K to 274.5 K (-0.39 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 182.68 | 1,177 | 215,014 | 275,569 | 276.7 K to 275.6 K (-0.43 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 181.71 | 7,362 | 1,337,749 | 276,746 | 284.1 K to 276.7 K (-2.59 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 180.05 | 196 | 35,290 | 284,108 | 284.3 K to 284.1 K (-0.07 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 183.36 | 4 | 733 | 2,159 | 2.2 K to 2.2 K (-0.18 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 179.98 | 797 | 143,444 | 2,163 | 3 K to 2.2 K (-26.93 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,310 | 0 | 2,960 | 1.7 K to 3 K (+79.39 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 183.36 | 4 | 733 | 5,589 | 5.6 K to 5.6 K (-0.07 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 179.98 | 797 | 143,444 | 5,593 | 6.4 K to 5.6 K (-12.47 %) |
Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,310 | 0 | 6,390 | 5.1 K to 6.4 K (+25.79 %) |
Jul 16 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | M | 46.83 | 4,000 | 187,320 | 38,632 | |
Jul 16 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 177.79 | 4,000 | 711,160 | 46,420 | 50.4 K to 46.4 K (-7.93 %) |
Jul 16 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Buy | M | 46.83 | 4,000 | 187,320 | 50,420 | 46.4 K to 50.4 K (+8.62 %) |
Jul 16 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 177.79 | 5,000 | 888,950 | 542,224 | 547.2 K to 542.2 K (-0.91 %) |
Jul 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 178.59 | 10 | 1,786 | 5,696 | 5.7 K to 5.7 K (-0.18 %) |
Jul 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 177.74 | 60 | 10,665 | 5,706 | 5.8 K to 5.7 K (-1.04 %) |
Jul 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.86 | 105 | 18,570 | 5,766 | 5.9 K to 5.8 K (-1.79 %) |
Jul 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.81 | 22 | 3,868 | 5,871 | 5.9 K to 5.9 K (-0.37 %) |
Jul 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 178.59 | 543 | 96,977 | 284,304 | 284.8 K to 284.3 K (-0.19 %) |
Jul 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 177.74 | 2,986 | 530,727 | 284,847 | 287.8 K to 284.8 K (-1.04 %) |
Jul 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.86 | 5,196 | 918,943 | 287,833 | 293 K to 287.8 K (-1.77 %) |
Jul 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.81 | 1,078 | 189,520 | 293,029 | 294.1 K to 293 K (-0.37 %) |
Jun 11 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | M | 46.83 | 4,000 | 187,320 | 42,632 | |
Jun 11 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 173.16 | 4,000 | 692,640 | 46,420 | 50.4 K to 46.4 K (-7.93 %) |
Jun 11 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Buy | M | 46.83 | 4,000 | 187,320 | 50,420 | 46.4 K to 50.4 K (+8.62 %) |
Jun 11 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 173.16 | 5,000 | 865,800 | 547,224 | 552.2 K to 547.2 K (-0.91 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 59.13 | 1,500 | 88,695 | 4,750 | |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 3,994 | 187,039 | 6,708 | |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 180.00 | 257 | 46,260 | 25,642 | 25.9 K to 25.6 K (-0.99 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 179.50 | 3,994 | 716,923 | 25,899 | 29.9 K to 25.9 K (-13.36 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 3,994 | 187,039 | 29,893 | 25.9 K to 29.9 K (+15.42 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 179.75 | 1,500 | 269,625 | 25,899 | 27.4 K to 25.9 K (-5.47 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 59.13 | 1,500 | 88,695 | 27,399 | 25.9 K to 27.4 K (+5.79 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 179.43 | 47 | 8,433 | 5,893 | 5.9 K to 5.9 K (-0.79 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 178.76 | 109 | 19,485 | 5,940 | 6 K to 5.9 K (-1.80 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 177.82 | 40 | 7,113 | 6,049 | 6.1 K to 6 K (-0.66 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 179.43 | 2,397 | 430,099 | 294,107 | 296.5 K to 294.1 K (-0.81 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 178.76 | 5,447 | 973,685 | 296,504 | 302 K to 296.5 K (-1.80 %) |
Jun 03 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 177.82 | 1,960 | 348,521 | 301,951 | 303.9 K to 302 K (-0.64 %) |
May 28 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe and Res ... | Option Exercise | M | 59.13 | 1,500 | 88,695 | 5,500 | |
May 28 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe and Res ... | Option Exercise | M | 46.83 | 5,834 | 273,206 | 12,500 | |
May 28 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe and Res ... | Sell | S | 179.48 | 7,334 | 1,316,326 | 24,696 | 32 K to 24.7 K (-22.90 %) |
May 28 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe and Res ... | Buy | M | 59.13 | 1,500 | 88,695 | 32,030 | 30.5 K to 32 K (+4.91 %) |
May 28 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe and Res ... | Buy | M | 46.83 | 5,834 | 273,206 | 30,530 | 24.7 K to 30.5 K (+23.62 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 176.60 | 801 | 141,457 | 27,662 | 28.5 K to 27.7 K (-2.81 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | M | 46.83 | 2,073 | 97,079 | 46,632 | |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 173.85 | 4,000 | 695,400 | 46,297 | 50.3 K to 46.3 K (-7.95 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Buy | M | 46.83 | 2,073 | 97,079 | 50,297 | 48.2 K to 50.3 K (+4.30 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 173.85 | 5,000 | 869,250 | 551,967 | 557 K to 552 K (-0.90 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | M | 46.83 | 4,500 | 210,735 | 0 | |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 174.90 | 1,218 | 213,026 | 9,432 | 10.7 K to 9.4 K (-11.44 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Buy | M | 46.83 | 4,500 | 210,735 | 10,650 | 6.2 K to 10.7 K (+73.17 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 175.10 | 6 | 1,051 | 4,356 | 4.4 K to 4.4 K (-0.14 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 173.85 | 644 | 111,959 | 4,362 | 5 K to 4.4 K (-12.86 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 175.15 | 7 | 1,226 | 4,946 | 5 K to 4.9 K (-0.14 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 173.85 | 697 | 121,173 | 4,953 | 5.7 K to 5 K (-12.34 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Option Exercise | A | 176.51 | 15,516 | 2,738,729 | 15,516 | |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Option Exercise | A | 176.51 | 2,264 | 399,619 | 2,264 | |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Grant | A | 0.00 | 275 | 0 | 7,105 | 6.8 K to 7.1 K (+4.03 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Grant | A | 0.00 | 6,830 | 0 | 6,830 | 0 to 6.8 K |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.63 | 60 | 10,598 | 6,089 | 6.1 K to 6.1 K (-0.98 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.98 | 137 | 24,109 | 6,149 | 6.3 K to 6.1 K (-2.18 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.64 | 3,022 | 533,800 | 303,911 | 306.9 K to 303.9 K (-0.98 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.98 | 6,781 | 1,193,289 | 306,933 | 313.7 K to 306.9 K (-2.16 %) |
May 06 2015 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | SVP, US Commercial | Payment of Exercise | F | 176.42 | 939 | 165,658 | 13,921 | 14.9 K to 13.9 K (-6.32 %) |
May 06 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 183.23 | 1,127 | 206,500 | 28,463 | 29.6 K to 28.5 K (-3.81 %) |
Apr 16 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 181.45 | 500 | 90,725 | 64,553 | 65.1 K to 64.6 K (-0.77 %) |
Apr 16 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 181.45 | 4,000 | 725,800 | 48,224 | 52.2 K to 48.2 K (-7.66 %) |
Apr 16 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 181.45 | 5,000 | 907,250 | 556,967 | 562 K to 557 K (-0.89 %) |
Apr 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 169.96 | 28 | 4,759 | 6,286 | 6.3 K to 6.3 K (-0.44 %) |
Apr 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 169.23 | 125 | 21,154 | 6,314 | 6.4 K to 6.3 K (-1.94 %) |
Apr 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 168.31 | 43 | 7,237 | 6,439 | 6.5 K to 6.4 K (-0.66 %) |
Apr 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 169.97 | 1,402 | 238,301 | 313,714 | 315.1 K to 313.7 K (-0.44 %) |
Apr 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 169.24 | 6,275 | 1,061,958 | 315,116 | 321.4 K to 315.1 K (-1.95 %) |
Apr 08 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 168.32 | 2,127 | 358,008 | 321,391 | 323.5 K to 321.4 K (-0.66 %) |
Mar 27 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 181.80 | 475 | 86,355 | 1,157,205 | 1.2 M to 1.2 M (-0.04 %) |
Mar 27 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 179.04 | 200 | 35,808 | 1,157,680 | 1.2 M to 1.2 M (-0.02 %) |
Mar 27 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 178.13 | 4,321 | 769,714 | 1,157,880 | 1.2 M to 1.2 M (-0.37 %) |
Mar 27 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 177.08 | 4,300 | 761,446 | 1,162,201 | 1.2 M to 1.2 M (-0.37 %) |
Mar 27 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 176.07 | 4,300 | 757,105 | 1,166,501 | 1.2 M to 1.2 M (-0.37 %) |
Mar 27 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 174.87 | 8,171 | 1,428,883 | 1,170,801 | 1.2 M to 1.2 M (-0.69 %) |
Mar 27 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 173.82 | 10,977 | 1,908,000 | 1,178,972 | 1.2 M to 1.2 M (-0.92 %) |
Mar 27 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 173.00 | 13,801 | 2,387,510 | 1,189,949 | 1.2 M to 1.2 M (-1.15 %) |
Mar 27 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 172.13 | 3,455 | 594,702 | 1,203,750 | 1.2 M to 1.2 M (-0.29 %) |
Mar 20 2015 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 185.00 | 50,000 | 9,250,000 | 1,207,205 | 1.3 M to 1.2 M (-3.98 %) |
Mar 12 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | M | 46.83 | 1,851 | 86,682 | 48,705 | |
Mar 12 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 170.36 | 1,851 | 315,336 | 52,224 | 54.1 K to 52.2 K (-3.42 %) |
Mar 12 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Buy | M | 46.83 | 1,851 | 86,682 | 54,075 | 52.2 K to 54.1 K (+3.54 %) |
Mar 12 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 170.35 | 5,000 | 851,750 | 561,967 | 567 K to 562 K (-0.88 %) |
Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 174.76 | 563 | 98,390 | 25,642 | 26.2 K to 25.6 K (-2.15 %) |
Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, R&D & CMO | Payment of Exercise | F | 174.76 | 1,630 | 284,859 | 38,484 | 40.1 K to 38.5 K (-4.06 %) |
Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | Head of EUSA Int'l ... | Payment of Exercise | F | 174.76 | 818 | 142,954 | 24,696 | 25.5 K to 24.7 K (-3.21 %) |
Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 174.76 | 2,087 | 364,724 | 52,224 | 54.3 K to 52.2 K (-3.84 %) |
Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Sell | S | 175.10 | 500 | 87,550 | 65,053 | 65.6 K to 65.1 K (-0.76 %) |
Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 174.76 | 1,571 | 274,548 | 65,553 | 67.1 K to 65.6 K (-2.34 %) |
Mar 09 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 174.76 | 6,522 | 1,139,785 | 566,967 | 573.5 K to 567 K (-1.14 %) |
Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 46.83 | 152 | 7,118 | 2,896 | |
Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | M | 27.46 | 5,007 | 137,492 | 0 | |
Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 27.46 | 5,007 | 137,492 | 26,205 | 21.2 K to 26.2 K (+23.62 %) |
Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Buy | M | 46.83 | 152 | 7,118 | 21,198 | 21 K to 21.2 K (+0.72 %) |
Mar 05 2015 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 176.27 | 2,598 | 457,949 | 21,046 | 23.6 K to 21 K (-10.99 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 177.51 | 3 | 533 | 6,482 | 6.5 K to 6.5 K (-0.05 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.79 | 87 | 15,381 | 6,485 | 6.6 K to 6.5 K (-1.32 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.03 | 57 | 10,033 | 6,572 | 6.6 K to 6.6 K (-0.86 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.06 | 38 | 6,652 | 6,629 | 6.7 K to 6.6 K (-0.57 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 172.60 | 12 | 2,071 | 6,667 | 6.7 K to 6.7 K (-0.18 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 177.51 | 197 | 34,969 | 323,518 | 323.7 K to 323.5 K (-0.06 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.79 | 4,302 | 760,560 | 323,715 | 328 K to 323.7 K (-1.31 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.02 | 2,854 | 502,374 | 328,017 | 330.9 K to 328 K (-0.86 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.06 | 1,862 | 325,969 | 330,871 | 332.7 K to 330.9 K (-0.56 %) |
Mar 04 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 172.60 | 588 | 101,488 | 332,733 | 333.3 K to 332.7 K (-0.18 %) |
Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 175.19 | 19,430 | 3,403,942 | 19,430 |